½ÃÀ庸°í¼­
»óǰÄÚµå
1825466

¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå º¸°í¼­(2025³â)

Molecular Modeling Global Market Report 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºÐÀÚ ¸ðµ¨¸µ ½ÃÀåÀÇ ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 16.0%·Î 170¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº AI¿Í ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕ, ½Å¾à °³¹ß ¿ä±¸ Áõ°¡, Àç·á °úÇп¡¼­ÀÇ ÀÀ¿ë È®´ë, Á¤¹ÐÀÇ·á¿Í ¸ÂÃãÇü Ä¡·á Á¢±Ù¹ý, °¡»ó ½ºÅ©¸®´×¿¡¼­ÀÇ ÀÌ¿ë È®´ë µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ÁÖ¿ä µ¿Çâ¿¡´Â °è»ê ´É·ÂÀÇ Áøº¸, AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ½Å¾à °³¹ßÀÇ ¼ºÀå, Àç·á °úÇÐ ÀÀ¿ëÀÇ È®´ë, ¿¹ÃøÀÇ·á¿¡ ´ëÇÑ ÁÖ·Â µîÀÌ Æ÷ÇԵ˴ϴÙ.

ÇâÈÄ 5³â°£ÀÇ ¿¹Ãø ¼ºÀå·ü 16.0%´Â °ú°Å ¿¹Ãø¿¡¼­ 0.1% ¼ÒÆø °¨¼ÒÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¼¼ µÐÈ­´Â ÁÖ·Î ¹Ì±¹°ú ´Ù¸¥ ±¹°¡ °£ÀÇ °ü¼¼ÀÇ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. ¹«¿ª ¸¶ÂûÀº ÇÁ¶û½º¿Í ij³ª´Ù¿¡¼­ °³¹ßµÈ ¾çÀÚ ÄÄÇ»ÆÃ Ŭ¶ó¿ìµå Ç÷§Æû°ú ÀΰøÁö´É(AI) ±â¹Ý ´Ü¹éÁú Æúµù ¼ÒÇÁÆ®¿þ¾îÀÇ °¡°ÝÀ» Áõ°¡½ÃÄÑ ¹Ì±¹ÀÇ ½Å¾à °³¹ß¿¡ ÁöÀåÀ» ÃÊ·¡ÇÏ¿© Ä¡·á¹ýÀÇ °³¹ßÀÌ Áö¿¬µÇ°í °è»ê »ý¹°ÇÐÀÇ ÁöÃâÀÌ Áõ°¡ÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ »óÈ£°ü¼¼¿Í ¹«¿ªÀÇ ±äÀå°ú ÇѰè Áõ°¡·Î ÀÎÇÑ ¼¼°è °æÁ¦¿Í ¹«¿ª¿¡ ´ëÇÑ ¾Ç¿µÇâÀ¸·Î ÀÎÇØ ±× ¿µÇâÀÌ ´õ¿í ±¤¹üÀ§ÇØÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÐÀÚ ¸ðµ¨¸µ ½ÃÀåÀº ÀǾàǰ °³¹ßÀÇ Ãß¼¼°¡ ³ô¾ÆÁö¸é¼­ ¼ºÀå¼¼¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù. ÀǾàǰ °³¹ß¿¡´Â »õ·Î¿î ÀǾà È­ÇÕ¹°ÀÇ ¹ß°ß, ¼³°è, ½ÃÇè, ½ÃÀå Ãâ½Ã µîÀÇ º¹ÀâÇÑ ÇÁ·Î¼¼½º°¡ Æ÷ÇԵ˴ϴÙ. ºÐÀÚ ¸ðµ¨¸µÀº ºÐÀÚ°£ »óÈ£ÀÛ¿ëÀÇ ÀÌÇØ, ´Ü¹éÁú-¸®°£µå º¹ÇÕüÀÇ ¾ÈÁ¤¼º Æò°¡, ±â´ÉÀû ½Å·Ú¼º È®º¸, ¾àÈ¿ Æò°¡ µîÀ» Áö¿øÇϸç, ÀÌ °úÁ¤¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ij³ª´ÙÀÇ Á¢±Ù¼º Ç¥ÁØ º¸°í¿¡ µû¸£¸é 2022³â¿¡ ÀÓ»ó½ÃÇèÀÌ ½Ç½ÃµÈ ½Å¾àÀº ¾à 9,000°³ ǰ¸ñÀ¸·Î Àü³âÀÇ ¾à 8,500°³ ǰ¸ñ¿¡¼­ Å©°Ô Áõ°¡ÇÏ¿´½À´Ï´Ù. ÀÌ·¯ÇÑ ÀǾàǰ °³¹ß Ȱµ¿ÀÇ ±ÞÁõÀº ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ±âÆøÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ : PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå(2019-2024³â)
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå(2024-2029³â, 2034F)
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ : ÃÑ ½ÃÀå ±Ô¸ð(TAM)

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : Á¦Ç°º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : Á¢±Ù¹ýº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • ºÐÀÚ¿ªÇÐ Á¢±Ù
  • ¾çÀÚÈ­ÇÐ Á¢±Ù
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ¿ëµµº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • ÀǾàǰ °³¹ß
  • ½Å¾à °³¹ß
  • ±âŸ ¿ëµµ
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • Á¦¾à ¹× »ý¸í°øÇбâ¾÷
  • ¿¬±¸¼¾ÅÍ ¹× Çмú±â°ü
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ¼¼ºÐÈ­ ¼ÒÇÁÆ®¿þ¾î(À¯Çüº°), ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • ºÐÀÚ ½Ã°¢È­ ¼ÒÇÁÆ®¿þ¾î
  • ºÐÀÚµ¿¿ªÇÐ ¼ÒÇÁÆ®¿þ¾î
  • ¾çÀÚÈ­ÇÐ ¼ÒÇÁÆ®¿þ¾î
  • µµÅ· ¼ÒÇÁÆ®¿þ¾î
  • ½Ã¹Ä·¹ÀÌ¼Ç ¼ÒÇÁÆ®¿þ¾î
  • ±âŸ Àü¹® ¼ÒÇÁÆ®¿þ¾î
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ¼¼ºÐÈ­ ¼­ºñ½º(À¯Çüº°), ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • ÄÁ¼³ÆÃ ¼­ºñ½º
  • Ä¿½ºÅÒ ¸ðµ¨¸µ ¼­ºñ½º
  • ±³À° ¹× Áö¿ø ¼­ºñ½º
  • µ¥ÀÌÅÍ ºÐ¼® ¼­ºñ½º
  • Ŭ¶ó¿ìµå ±â¹Ý ¼­ºñ½º

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : Áö¿ªº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)
  • ¼¼°èÀÇ ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ±¹°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029F, 2034F)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : °æÀï ±¸µµ
  • ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Thermo Fisher Scientific Inc. : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • BioNTech SE : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Dassault Systemes SE : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Bruker Corporation : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Qiagen NV : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

  • Physiomics plc
  • SilcsBio LLC
  • Compugen Ltd.
  • Certara Inc.
  • Schrodinger Inc.
  • Jubilant Biosys Ltd.
  • Simulations Plus Inc.
  • Genedata AG
  • Labvantage-Biomax GmbH
  • Acellera Ltd.
  • Advanced Chemistry Development Inc.
  • Molsoft LLC
  • Nimbus Therapeutics Inc.
  • Crown Bioscience Inc.
  • OTAVA Ltd.

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

  • ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ºÐÀÚ ¸ðµ¨¸µ ½ÃÀå(2029³â) : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ±âÃÊÇÑ Àü·«
    • °æÀï Àü·«

Á¦36Àå ºÎ·Ï

CSM

Molecular modeling involves the generation, representation, and/or manipulation of three-dimensional structures of chemical and biological molecules, along with determining physicochemical attributes. This process aids in understanding the Structural Activity Relationship (SAR) of biological molecules. Molecular modeling relies on computer programs and mathematical algorithms to predict and visualize the three-dimensional structure and properties of molecules.

The primary products of molecular modeling include software and services. Software encompasses a set of instructions, data, and programs that enable a computer or computing device to perform specific tasks, solve problems, or carry out operations. Molecular modeling employs approaches such as the molecular mechanics approach and quantum chemistry approach, particularly in applications such as drug development and drug discovery. End users of molecular modeling include pharmaceutical and biotechnology companies, research centers, academic institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The molecular modeling market research report is one of a series of new reports from The Business Research Company that provides molecular modeling market statistics, including molecular modeling industry global market size, regional shares, competitors with a molecular modeling market share, detailed molecular modeling market segments, market trends and opportunities, and any further data you may need to thrive in the molecular modeling industry. This molecular modeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular modeling market size has grown rapidly in recent years. It will grow from $8.25 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to computational chemistry and molecular dynamics, early environmental and sustainability applications, enhanced visualization tools, increased use in enzyme and protein engineering, development of biomolecular modeling techniques.

The molecular modeling market size is expected to see rapid growth in the next few years. It will grow to $17.07 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to integration of ai and machine learning algorithms, rise in drug discovery and development needs, expanding applications in material science, precision medicine and personalized treatment approaches, increasing utilization in virtual screening. Major trends in the forecast period include advancements in computational power, ai and machine learning integration, growth in drug discovery and development, expansion in material science applications, focus on predictive medicine.

The forecast of 16.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug discovery by inflating prices of quantum computing cloud platforms and Artificial intelligence(AI)-based protein folding software developed in France and Canada, resulting in delayed therapeutic development and higher computational biology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The molecular modeling market is poised for growth, driven by the increasing momentum in drug development. Drug development encompasses the intricate process of discovering, designing, testing, and bringing new pharmaceutical compounds to market. Molecular modeling plays a pivotal role in this journey, aiding in understanding molecular interactions, assessing protein-ligand complex stability, ensuring functional reliability, and evaluating drug efficacy. A noteworthy surge in drug development is evident, with Accessibility Standards Canada reporting around 9,000 novel medications undergoing clinical trials in 2022, reflecting a substantial increase from the previous year's approximate count of 8,500 drugs. This surge in drug development activities is a key catalyst for the growth of the molecular modeling market.

The driving force for the molecular modeling market is the rise of personalized medicine. Personalized medicine tailors healthcare decisions and treatments based on an individual's unique genetic, molecular, and clinical characteristics. Molecular modeling is integral to this approach, facilitating the prediction of individual patient responses to treatments, the design of personalized drug therapies, and the optimization of treatment regimens based on molecular profiles. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and approximately 34% of therapeutic NMEs, accounting for 12 of them, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). The ascendancy of personalized medicine is a significant driver propelling the molecular modeling market forward.

The molecular modeling market faces a constraint due to the scarcity of experienced healthcare personnel. Adequate knowledge and expertise among healthcare professionals are essential for the effective interpretation and application of molecular modeling data in medical research and drug development. A significant shortage of essential healthcare workers has been reported, with projections indicating a worsening deficit of over 3.2 million workers within the next five years, as per a report by Mercer in September 2021. This shortage of experienced healthcare personnel poses a hindrance to the widespread adoption and utilization of molecular modeling techniques in the healthcare and pharmaceutical industries, thereby limiting the growth of the molecular modeling market.

Major companies in the molecular modeling market are at the forefront of innovation, introducing new technologies such as molecular modeling platforms. These platforms are comprehensive software suites offering tools for visualizing, simulating, and analyzing molecules. For instance, Cresset Group unveiled Flare V7 in August 2023, representing a cutting-edge drug design platform that seamlessly integrates ligand and structure-based approaches to enhance small-molecule discovery. It incorporates ensemble docking, Quantum Mechanics (QM) and Quantitative Structure-Activity Relationship (QSAR) methodologies, and various tools, marking a significant advancement in molecular modeling.

Major companies operating in the molecular modeling market report are Thermo Fisher Scientific Inc., BioNTech SE, Dassault Systemes SE, Bruker Corporation, Qiagen N.V., Physiomics PLC, SilcsBio LLC, Compugen Ltd., Certara Inc., Schrodinger Inc., Jubilant Biosys Ltd., Simulations Plus Inc., Genedata AG, Labvantage-Biomax GmbH, Acellera Ltd., Advanced Chemistry Development Inc., Molsoft L.L.C., Nimbus Therapeutics Inc., Crown Bioscience Inc., OTAVA Ltd., Chemical Computing Group, Molport SIA, Optibrium Ltd., BioSolveIT GmbH, Cyclica Inc., Cresset Group, Cyrus Biotechnology Inc., 3D Molecular Designs LLC, Inhibrx Inc., Leadscope Inc.

North America was the largest region in the molecular modeling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular modeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the molecular modeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The molecular modeling market consists of revenues earned by entities by providing services such as molecular modeling consultancy services, computational chemistry services, receptor-based and ligand-based virtual screening, and in silico screening and molecular modeling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular modeling market also includes sales of protein modeling and drug discovery tools, cheminformatics and computational chemistry databases, and visualization and molecular graphics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Modeling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on molecular modeling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular modeling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular modeling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Software; Services
  • 2) By Approach: Molecular Mechanics Approach; Quantum Chemistry Approach
  • 3) By Application: Drug Development; Drug Discovery; Other Applications
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Research Centers And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Software: Molecular Visualization Software; Molecular Dynamics Software; Quantum Chemistry Software; Docking Software; Simulation Software; Other Specialized Software
  • 2) By Services: Consulting Services; Custom Modeling Services; Training And Support Services; Data Analysis Services; Cloud-Based Services
  • Companies Mentioned: Thermo Fisher Scientific Inc.; BioNTech SE; Dassault Systemes SE; Bruker Corporation; Qiagen N.V.; Physiomics plc; SilcsBio LLC; Compugen Ltd.; Certara Inc.; Schrodinger Inc.; Jubilant Biosys Ltd.; Simulations Plus Inc. ; Genedata AG ; Labvantage-Biomax GmbH; Acellera Ltd.; Advanced Chemistry Development Inc.; Molsoft L.L.C.; Nimbus Therapeutics Inc.; Crown Bioscience Inc.; OTAVA Ltd.; Chemical Computing Group; Molport SIA; Optibrium Ltd.; BioSolveIT GmbH; Cyclica Inc.; Cresset Group; Cyrus Biotechnology Inc.; 3D Molecular Designs LLC; Inhibrx Inc.; Leadscope Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Molecular Modeling Market Characteristics

3. Molecular Modeling Market Trends And Strategies

4. Molecular Modeling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Molecular Modeling Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Molecular Modeling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Molecular Modeling Market Growth Rate Analysis
  • 5.4. Global Molecular Modeling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Molecular Modeling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Molecular Modeling Total Addressable Market (TAM)

6. Molecular Modeling Market Segmentation

  • 6.1. Global Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.2. Global Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Mechanics Approach
  • Quantum Chemistry Approach
  • 6.3. Global Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Development
  • Drug Discovery
  • Other Applications
  • 6.4. Global Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Research Centers And Academic Institutions
  • Other End Users
  • 6.5. Global Molecular Modeling Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Visualization Software
  • Molecular Dynamics Software
  • Quantum Chemistry Software
  • Docking Software
  • Simulation Software
  • Other Specialized Software
  • 6.6. Global Molecular Modeling Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Custom Modeling Services
  • Training And Support Services
  • Data Analysis Services
  • Cloud-Based Services

7. Molecular Modeling Market Regional And Country Analysis

  • 7.1. Global Molecular Modeling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Molecular Modeling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Molecular Modeling Market

  • 8.1. Asia-Pacific Molecular Modeling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Molecular Modeling Market

  • 9.1. China Molecular Modeling Market Overview
  • 9.2. China Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Molecular Modeling Market

  • 10.1. India Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Molecular Modeling Market

  • 11.1. Japan Molecular Modeling Market Overview
  • 11.2. Japan Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Molecular Modeling Market

  • 12.1. Australia Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Molecular Modeling Market

  • 13.1. Indonesia Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Molecular Modeling Market

  • 14.1. South Korea Molecular Modeling Market Overview
  • 14.2. South Korea Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Molecular Modeling Market

  • 15.1. Western Europe Molecular Modeling Market Overview
  • 15.2. Western Europe Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Molecular Modeling Market

  • 16.1. UK Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Molecular Modeling Market

  • 17.1. Germany Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Molecular Modeling Market

  • 18.1. France Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Molecular Modeling Market

  • 19.1. Italy Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Molecular Modeling Market

  • 20.1. Spain Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Molecular Modeling Market

  • 21.1. Eastern Europe Molecular Modeling Market Overview
  • 21.2. Eastern Europe Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Molecular Modeling Market

  • 22.1. Russia Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Molecular Modeling Market

  • 23.1. North America Molecular Modeling Market Overview
  • 23.2. North America Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Molecular Modeling Market

  • 24.1. USA Molecular Modeling Market Overview
  • 24.2. USA Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Molecular Modeling Market

  • 25.1. Canada Molecular Modeling Market Overview
  • 25.2. Canada Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Molecular Modeling Market

  • 26.1. South America Molecular Modeling Market Overview
  • 26.2. South America Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Molecular Modeling Market

  • 27.1. Brazil Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Molecular Modeling Market

  • 28.1. Middle East Molecular Modeling Market Overview
  • 28.2. Middle East Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Molecular Modeling Market

  • 29.1. Africa Molecular Modeling Market Overview
  • 29.2. Africa Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Molecular Modeling Market Competitive Landscape And Company Profiles

  • 30.1. Molecular Modeling Market Competitive Landscape
  • 30.2. Molecular Modeling Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Molecular Modeling Market Other Major And Innovative Companies

  • 31.1. Physiomics plc
  • 31.2. SilcsBio LLC
  • 31.3. Compugen Ltd.
  • 31.4. Certara Inc.
  • 31.5. Schrodinger Inc.
  • 31.6. Jubilant Biosys Ltd.
  • 31.7. Simulations Plus Inc.
  • 31.8. Genedata AG
  • 31.9. Labvantage-Biomax GmbH
  • 31.10. Acellera Ltd.
  • 31.11. Advanced Chemistry Development Inc.
  • 31.12. Molsoft L.L.C.
  • 31.13. Nimbus Therapeutics Inc.
  • 31.14. Crown Bioscience Inc.
  • 31.15. OTAVA Ltd.

32. Global Molecular Modeling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Molecular Modeling Market

34. Recent Developments In The Molecular Modeling Market

35. Molecular Modeling Market High Potential Countries, Segments and Strategies

  • 35.1 Molecular Modeling Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Molecular Modeling Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Molecular Modeling Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦